Rifampin hypersensitivity in a two year-old child with successful rapid oral desensitization by Hildebrand, KJ & Hummel, D
POSTER PRESENTATION Open Access
Rifampin hypersensitivity in a two year-old child
with successful rapid oral desensitization
KJ Hildebrand
*, D Hummel
From Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2009
Halifax, Canada. 22-25 October 2009
A two year, 10 month-old child was referred to a ter-
tiary allergy clinic following an adverse reaction to
rifampin. Her mother had isoniazid-resistant pulmonary
tuberculosis. The child was born in Canada, was asymp-
tomatic, had a normal chest x-ray and liver enzymes.
Mantoux induration was 17 mm. The child was pre-
scribed oral rifampin, 150 mg per day for 3 months.
Thirty minutes after ingesting the fifth dose, she devel-
oped swelling of the lips, eyes and face; and a pruritic
rash to the extremities and face. Anti-histamine was
administered: the rash resolved over thirty minutes and
facial swelling over 2-3 hours. There were no other IgE-
mediated symptoms. Rifampin was discontinued. Past
history was negative for atopy, adverse drug reactions,
and food allergies.
Intravenous rifampin (600 mg/mL) was used for skin
prick and intradermal testing. The patient was admitted
to hospital and intravenous access established. Skin
prick test results were negative to undiluted rifampin
and saline; the histamine response was positive (5 mm).
Intradermal testing was performed at 15-minute inter-
vals with dilutions of 1:10,000, 1:1000 and 1:100. The
1:100 dilution test was positive.
Rapid desensitization to oral rifampin was performed
over 3.25 hours. The first dose was 1/10,000 of the total
dose. Thirteen incremental doses were administered
every 15 minutes until a cumulative dose of 151.08 mg
had been ingested (Table 1). No adverse events were
noted. The child was subsequently continued on a dose
of oral rifampin 75 mg twice daily and has not had sub-
sequent reactions.
This case highlights the rare occurrence of rifampin
hypersensitivity in a child. Desensitization was motivated
by the lack of alternative therapies. Rifampin desensiti-
zation protocols preciously reported have occurred
predominantly in the adult population over several days.
W ed e s c r i b eac a s eo fr a p i do r a ld e s e n s i t i z a t i o nt o
rifampin in a two year-old child.
Published: 12 May 2010
doi:10.1186/1710-1492-6-S1-P22
Cite this article as: Hildebrand and Hummel: Rifampin hypersensitivity in
a two year-old child with successful rapid oral desensitization. Allergy,
Asthma & Clinical Immunology 2010 6(Suppl 1):P22.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Division of allergy and clinical Immunology at the Hospital for Sick Children
and the University of Toronto, Canada
Hildebrand and Hummel Allergy, Asthma & Clinical Immunology 2010, 6(Suppl 1):P22
http://www.aacijournal.com/content/6/S1/P22 ALLERGY, ASTHMA & CLINICAL 
IMMUNOLOGY
© 2010 Hildebrand and Hummel; licensee BioMed Central Ltd.